Canada markets closed

Frequency Therapeutics, Inc. (FREQ)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.1100-0.1600 (-12.60%)
At close: 04:00PM EDT
1.1600 +0.05 (+4.50%)
After hours: 05:09PM EDT
Full screen
Loading interactive chart...
  • Business Wire

    Frequency Therapeutics to Participate in 2022 H.C. Wainwright Global Investment Conference

    LEXINGTON, Mass., May 18, 2022--Frequency Therapeutics, Inc. (Nasdaq: FREQ), a clinical-stage regenerative medicine company focused on developing therapeutics to activate a person’s innate regenerative potential to restore function, today announced that Chief Scientific Officer Dr. Christopher Loose will present at the upcoming H.C. Wainwright Global Investment Conference.

  • Business Wire

    Frequency Therapeutics Provides Business Updates and First Quarter 2022 Financial Results

    LEXINGTON, Mass., May 04, 2022--Frequency Therapeutics, Inc. (Nasdaq: FREQ), a clinical-stage regenerative medicine company focused on developing therapeutics to activate a person’s innate regenerative potential to restore function, today announced business updates and financial results for the first quarter ended March 31, 2022.

  • Business Wire

    Frequency Therapeutics to Participate in B. Riley Securities’ Neuro & Ophthalmology Investor Conference

    LEXINGTON, Mass., April 22, 2022--Frequency Therapeutics, Inc. (Nasdaq: FREQ), a clinical-stage regenerative medicine company focused on developing therapeutics to activate a person’s innate regenerative potential to restore function, today announced that Chief Scientific Officer Dr. Christopher Loose and Vice President of Discovery Biology Dr. Sanjay Magavi will participate in a fireside presentation at the B. Riley Securities’ Neuro & Ophthalmology Conference on April 28, 2022 at 3:30 pm ET.